- ￥1050 - 2300
- 泽叶生物
- ZY909450
- 中国
- 2025年07月14日
- 见说明书
- 小鼠
- Human, Mouse, Rattus Other species not tested.
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海泽叶生物科技有限公司
- 库存：
100
- 靶点：
见说明书
- 级别：
高
- 目录编号：
ZY909450
- 克隆性：
多克隆
- 抗原来源：
多抗制备
- 保质期：
2年
- 抗体英文名：
HERG
- 抗体名：
HERG
- 标记物：
无标记物
- 宿主：
小鼠
- 适应物种：
Human, Mouse, Rattus Other species not tested.
- 免疫原：
详见说明书
- 亚型：
Ig亚型IgG
- 形态：
液体或冻干粉
- 应用范围：
见说明书
- 保存条件：
-20°C
- 浓度：
0.5mg/ml
- 规格：
50ul/100ul/200ul
| 规格： | 50ul | 产品价格： | ￥1050.0 |
|---|---|---|---|
| 规格： | 100ul | 产品价格： | ￥1500.0 |
| 规格： | 200ul | 产品价格： | ￥2300.0 |
| Catalog No | ZY909450 |
|---|---|
| Species Reactivity | Human, Mouse, Rattus Other species not tested. |
| Immunogen | A peptide corresponding to middle region of human HERG protein. |
| GeneBank No. | NM_000238 |
| Alternative Names | ERG-1; ERG1; H-ERG; KCNH2; HERG1; Kv11.1; LQT2; SQT1 |
| Purification | Purified by antigen affinity column. |
| Isotype | IgG |
| Formulation | Lyophilized power with 1% BSA and 0.02% NaN3. Or dissolved in sterile H2O with 50% glycerol. |
| Concentration | 0.5mg/ml |
| Applications | |
|---|---|
| ELISA | 1:20,000-1:80,000 |
| Immunohistochemistry | 1:100-1:500 |
| Western blot | 1:200-1:1,000 |
| For research use only. Optimal dilutions/concentrations should be determined by the final use. | |
| DATA | |||
|---|---|---|---|
|
|||
| Observed Molecular Weight | 110kd 127kd | ||
| PREPARATION AND STORAGE | |
|---|---|
| Reconstitution | If lyophilized, reconstitute in indicated volume of sterile H2O. For extended storage, we suggest the addition of an equal volume of glycerol to make a final glycerol concentration of 50%. |
| Storage | Shipped at ambient temperature or with ice bags if in liquid. Store immediately at-20°C upon receipt. Avoid repeating freeze-thaw cycles. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验A High-Throughput Binding Assay for HERG
The human homologue of the ether-a-go-go -related-gene (HERG) has been implicated in the “iatrogenic” long QT syndrome, with several products withdrawn from the market because of their interaction with this K + channel. The resultant impact
Manual Whole-Cell Patch-Clamping of the HERG Cardiac K+ Channel
from direct pharmacological inhibition of the human ether-a-go-go- related gene (HERG) cardiac K+ channel. It is standard practice to test a drug’s ability to interact with the HERG channel prior to entry into clinical trials. This testing is used
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料
